{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:31:16Z","timestamp":1791423076843,"version":"4.3.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10549-020-05797-x","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T13:03:16Z","timestamp":1595077396000},"page":"333-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["CDH2\/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ"],"prefix":"10.1007","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5290-6726","authenticated-orcid":false,"given":"Marina A.","family":"Guvakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Prabakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"issue":"41","key":"5797_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","volume":"2010","author":"DC Allred","year":"2010","unstructured":"Allred DC (2010) Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr 2010(41):134\u2013138. https:\/\/doi.org\/10.1093\/jncimonographs\/lgq035","journal-title":"J Natl Cancer Inst Monogr"},{"key":"5797_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2017.00248","volume":"7","author":"KL Gorringe","year":"2017","unstructured":"Gorringe KL, Fox SB (2017) Ductal carcinoma in situ biology, biomarkers, and diagnosis. Front Oncol 7:248. https:\/\/doi.org\/10.3389\/fonc.2017.00248","journal-title":"Front Oncol"},{"issue":"1","key":"5797_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-017-4644-3","volume":"169","author":"SA Narod","year":"2018","unstructured":"Narod SA, Sopik V (2018) Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat 169(1):9\u201323. https:\/\/doi.org\/10.1007\/s10549-017-4644-3","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5797_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.suc.2007.01.006","volume":"87","author":"MJ O'Sullivan","year":"2007","unstructured":"O'Sullivan MJ, Morrow M (2007) Ductal carcinoma in situ\u2013current management. Surg Clin North Am 87(2):333\u2013351. https:\/\/doi.org\/10.1016\/j.suc.2007.01.006","journal-title":"Surg Clin North Am"},{"issue":"10","key":"5797_CR5","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/S1470-2045(16)30367-9","volume":"17","author":"JR Benson","year":"2016","unstructured":"Benson JR, Jatoi I, Toi M (2016) Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Lancet Oncol 17(10):e442\u2013e451. https:\/\/doi.org\/10.1016\/S1470-2045(16)30367-9","journal-title":"Lancet Oncol"},{"key":"5797_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.breast.2017.07.012","volume":"35","author":"M Toss","year":"2017","unstructured":"Toss M, Miligy I, Thompson AM, Khout H, Green AR, Ellis IO, Rakha EA (2017) Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review. Breast 35:151\u2013156. https:\/\/doi.org\/10.1016\/j.breast.2017.07.012","journal-title":"Breast"},{"issue":"5","key":"5797_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/jmri.25655","volume":"46","author":"MR Harowicz","year":"2017","unstructured":"Harowicz MR, Saha A, Grimm LJ, Marcom PK, Marks JR, Hwang ES, Mazurowski MA (2017) Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer? J Magn Reson Imaging 46(5):1332\u20131340. https:\/\/doi.org\/10.1002\/jmri.25655","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"5797_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jacr.2017.11.036","volume":"15","author":"B Shi","year":"2018","unstructured":"Shi B, Grimm LJ, Mazurowski MA, Baker JA, Marks JR, King LM, Maley CC, Hwang ES, Lo JY (2018) Prediction of occult invasive disease in ductal carcinoma in situ using deep learning features. J Am Coll Radiol 15(3):527\u2013534. https:\/\/doi.org\/10.1016\/j.jacr.2017.11.036","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"5797_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, Houssami N (2011) Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260(1):119\u2013128. https:\/\/doi.org\/10.1148\/radiol.11102368","journal-title":"Radiology"},{"issue":"5","key":"5797_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.breast.2012.06.012","volume":"21","author":"J Kim","year":"2012","unstructured":"Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, Moon HG, Cho N, Moon WK, Park IA, Noh DY (2012) Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast 21(5):641\u2013645. https:\/\/doi.org\/10.1016\/j.breast.2012.06.012","journal-title":"Breast"},{"issue":"4","key":"5797_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","volume":"200","author":"TW Yen","year":"2005","unstructured":"Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516\u2013526. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2004.11.012","journal-title":"J Am Coll Surg"},{"issue":"2","key":"5797_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","volume":"100","author":"LM McShane","year":"2006","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Statistics Subcommittee of NCIEWGoCD (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229\u2013235. https:\/\/doi.org\/10.1007\/s10549-006-9242-8","journal-title":"Breast Cancer Res Treat"},{"issue":"5\u20136","key":"5797_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1387\/ijdb.041793ld","volume":"48","author":"LD Derycke","year":"2004","unstructured":"Derycke LD, Bracke ME (2004) N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 48(5\u20136):463\u2013476. https:\/\/doi.org\/10.1387\/ijdb.041793ld","journal-title":"Int J Dev Biol"},{"issue":"4A","key":"5797_CR14","first-page":"1969","volume":"27","author":"U Jeschke","year":"2007","unstructured":"Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K (2007) Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Anticancer Res 27(4A):1969\u20131974","journal-title":"Anticancer Res"},{"issue":"5","key":"5797_CR15","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/1055-9965.EPI-08-1101","volume":"18","author":"RE Roses","year":"2009","unstructured":"Roses RE, Paulson EC, Sharma A, Schueller JE, Nisenbaum H, Weinstein S, Fox KR, Zhang PJ, Czerniecki BJ (2009) HER-2\/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev 18(5):1386\u20131389. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-1101","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"5797_CR16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1210\/me.2010-0252","volume":"24","author":"AM Sanchez","year":"2010","unstructured":"Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, Simoncini T (2010) Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol 24(11):2114\u20132125. https:\/\/doi.org\/10.1210\/me.2010-0252","journal-title":"Mol Endocrinol"},{"issue":"2","key":"5797_CR17","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/bcr2853","volume":"13","author":"EA McSherry","year":"2011","unstructured":"McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM (2011) Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 13(2):R31. https:\/\/doi.org\/10.1186\/bcr2853","journal-title":"Breast Cancer Res"},{"issue":"244","key":"5797_CR18","doi-asserted-by":"publisher","first-page":"ra71","DOI":"10.1126\/scisignal.2002962","volume":"5","author":"C Citterio","year":"2012","unstructured":"Citterio C, Menacho-Marquez M, Garcia-Escudero R, Larive RM, Barreiro O, Sanchez-Madrid F, Paramio JM, Bustelo XR (2012) The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Sci Signal 5(244):ra71. https:\/\/doi.org\/10.1126\/scisignal.2002962","journal-title":"Sci Signal"},{"issue":"5","key":"5797_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.6061\/clinics\/2013(05)010","volume":"68","author":"FN Aguiar","year":"2013","unstructured":"Aguiar FN, Mendes HN, Cirqueira CS, Bacchi CE, Carvalho FM (2013) Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ. Clinics (Sao Paulo) 68(5):638\u2013643. https:\/\/doi.org\/10.6061\/clinics\/2013(05)010","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"5797_CR20","doi-asserted-by":"publisher","first-page":"e53532","DOI":"10.1371\/journal.pone.0053532","volume":"8","author":"SV Iyer","year":"2013","unstructured":"Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN, Vaidya MM (2013) Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS ONE 8(1):e53532. https:\/\/doi.org\/10.1371\/journal.pone.0053532","journal-title":"PLoS ONE"},{"issue":"12","key":"5797_CR21","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.18632\/oncotarget.2011","volume":"5","author":"S Grassilli","year":"2014","unstructured":"Grassilli S, Brugnoli F, Lattanzio R, Rossi C, Perracchio L, Mottolese M, Marchisio M, Palomba M, Nika E, Natali PG, Piantelli M, Capitani S, Bertagnolo V (2014) High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. Oncotarget 5(12):4320\u20134336. https:\/\/doi.org\/10.18632\/oncotarget.2011","journal-title":"Oncotarget"},{"issue":"2","key":"5797_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/BJ20131638","volume":"463","author":"MA Guvakova","year":"2014","unstructured":"Guvakova MA, Lee WS, Furstenau DK, Prabakaran I, Li DC, Hung R, Kushnir N (2014) The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I. Biochem J 463(2):257\u2013270. https:\/\/doi.org\/10.1042\/BJ20131638","journal-title":"Biochem J"},{"key":"5797_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2050-7771-2-22","volume":"2","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Prabakaran I, Wan F, Mitra N, Furstenau DK, Hung RK, Cao S, Zhang PJ, Fraker DL, Guvakova MA (2014) Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ. Biomark Res 2:22. https:\/\/doi.org\/10.1186\/2050-7771-2-22","journal-title":"Biomark Res"},{"key":"5797_CR24","doi-asserted-by":"publisher","first-page":"40138","DOI":"10.1038\/srep40138","volume":"7","author":"NA Afratis","year":"2017","unstructured":"Afratis NA, Bouris P, Skandalis SS, Multhaupt HA, Couchman JR, Theocharis AD, Karamanos NK (2017) IGF-IR cooperates with ERalpha to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules. Sci Rep 7:40138. https:\/\/doi.org\/10.1038\/srep40138","journal-title":"Sci Rep"},{"issue":"1","key":"5797_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc.2016.116","volume":"17","author":"JS Carroll","year":"2017","unstructured":"Carroll JS, Hickey TE, Tarulli GA, Williams M, Tilley WD (2017) Deciphering the divergent roles of progestogens in breast cancer. Nat Rev Cancer 17(1):54\u201364. https:\/\/doi.org\/10.1038\/nrc.2016.116","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"5797_CR26","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1158\/0008-5472.CAN-19-0573","volume":"79","author":"I Prabakaran","year":"2019","unstructured":"Prabakaran I, Wu Z, Lee C, Tong B, Steeman S, Koo G, Zhang PJ, Guvakova MA (2019) Gaussian Mixture Models for Probabilistic Classification of Breast Cancer. Cancer Res 79(13):3492\u20133502. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0573","journal-title":"Cancer Res"},{"issue":"2","key":"5797_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10549-010-1227-y","volume":"129","author":"DK Furstenau","year":"2011","unstructured":"Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, Fraker DL, Guvakova MA (2011) Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. Breast Cancer Res Treat 129(2):361\u2013372. https:\/\/doi.org\/10.1007\/s10549-010-1227-y","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5797_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2353\/jmoldx.2008.070127","volume":"10","author":"BS Knudsen","year":"2008","unstructured":"Knudsen BS, Allen AN, McLerran DF, Vessella RL, Karademos J, Davies JE, Maqsodi B, McMaster GK, Kristal AR (2008) Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues. J Mol Diagn 10(2):169\u2013176. https:\/\/doi.org\/10.2353\/jmoldx.2008.070127","journal-title":"J Mol Diagn"},{"key":"5797_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen EJ, Elshof LE, Visser LL, Rutgers EJT, Winter-Warnars HAO, Lips EH, Wesseling J (2017) Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast 31:274\u2013283. https:\/\/doi.org\/10.1016\/j.breast.2016.09.001","journal-title":"Breast"},{"issue":"11","key":"5797_CR30","first-page":"4556","volume":"61","author":"KO Toyooka","year":"2001","unstructured":"Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF (2001) Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61(11):4556\u20134560","journal-title":"Cancer Res"},{"issue":"16","key":"5797_CR31","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-05-0059","volume":"11","author":"J Paredes","year":"2005","unstructured":"Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC (2005) P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 11(16):5869\u20135877. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0059","journal-title":"Clin Cancer Res"},{"key":"5797_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2407-6-48","volume":"6","author":"JR Caldeira","year":"2006","unstructured":"Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR (2006) CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 6:48. https:\/\/doi.org\/10.1186\/1471-2407-6-48","journal-title":"BMC Cancer"},{"issue":"10","key":"5797_CR33","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1158\/1055-9965.EPI-08-0821","volume":"18","author":"MO Hoque","year":"2009","unstructured":"Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P (2009) Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev 18(10):2694\u20132700. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0821","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"5797_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0378-1119(97)00006-1","volume":"191","author":"B Li","year":"1997","unstructured":"Li B, Paradies NE, Brackenbury RW (1997) Isolation and characterization of the promoter region of the chicken N-cadherin gene. Gene 191(1):7\u201313","journal-title":"Gene"},{"issue":"3","key":"5797_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.147.3.631","volume":"147","author":"MT Nieman","year":"1999","unstructured":"Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147(3):631\u2013644","journal-title":"J Cell Biol"},{"issue":"4","key":"5797_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1083\/jcb.148.4.779","volume":"148","author":"RB Hazan","year":"2000","unstructured":"Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148(4):779\u2013790","journal-title":"J Cell Biol"},{"issue":"2","key":"5797_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0304-3835(01)00759-5","volume":"176","author":"U Cavallaro","year":"2002","unstructured":"Cavallaro U, Schaffhauser B, Christofori G (2002) Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176(2):123\u2013128","journal-title":"Cancer Lett"},{"issue":"11","key":"5797_CR38","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1245\/s10434-016-5268-2","volume":"23","author":"M Pilewskie","year":"2016","unstructured":"Pilewskie M, Stempel M, Rosenfeld H, Eaton A, Van Zee KJ, Morrow M (2016) Do LORIS trial eligibility criteria identify a ductal carcinoma in situ patient population at low risk of upgrade to invasive carcinoma? Ann Surg Oncol 23(11):3487\u20133493. https:\/\/doi.org\/10.1245\/s10434-016-5268-2","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"5797_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-005-7727-5","volume":"94","author":"C Nagi","year":"2005","unstructured":"Nagi C, Guttman M, Jaffer S, Qiao R, Keren R, Triana A, Li M, Godbold J, Bleiweiss IJ, Hazan RB (2005) N-cadherin expression in breast cancer: correlation with an aggressive histologic variant\u2013invasive micropapillary carcinoma. Breast Cancer Res Treat 94(3):225\u2013235. https:\/\/doi.org\/10.1007\/s10549-005-7727-5","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5797_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-015-3406-3","volume":"151","author":"MA Aleskandarany","year":"2015","unstructured":"Aleskandarany MA, Soria D, Green AR, Nolan C, Diez-Rodriguez M, Ellis IO, Rakha EA (2015) Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification. Breast Cancer Res Treat 151(2):325\u2013333. https:\/\/doi.org\/10.1007\/s10549-015-3406-3","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5797_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/bjs.8980","volume":"100","author":"S Saadatmand","year":"2013","unstructured":"Saadatmand S, de Kruijf EM, Sajet A, Dekker-Ensink NG, van Nes JG, Putter H, Smit VT, van de Velde CJ, Liefers GJ, Kuppen PJ (2013) Expression of cell adhesion molecules and prognosis in breast cancer. Br J Surg 100(2):252\u2013260. https:\/\/doi.org\/10.1002\/bjs.8980","journal-title":"Br J Surg"},{"issue":"11","key":"5797_CR42","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00432-014-1750-z","volume":"140","author":"C Bock","year":"2014","unstructured":"Bock C, Kuhn C, Ditsch N, Krebold R, Heublein S, Mayr D, Doisneau-Sixou S, Jeschke U (2014) Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events. J Cancer Res Clin Oncol 140(11):1873\u20131881. https:\/\/doi.org\/10.1007\/s00432-014-1750-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"5797_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0204-1","author":"WM Hanna","year":"2019","unstructured":"Hanna WM, Parra-Herran C, Lu FI, Slodkowska E, Rakovitch E, Nofech-Mozes S (2019) Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-019-0204-1","journal-title":"Mod Pathol"},{"issue":"Pt 5","key":"5797_CR44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1242\/jcs.01634","volume":"118","author":"M Maeda","year":"2005","unstructured":"Maeda M, Johnson KR, Wheelock MJ (2005) Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118(Pt 5):873\u2013887. https:\/\/doi.org\/10.1242\/jcs.01634","journal-title":"J Cell Sci"},{"issue":"5","key":"5797_CR45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"issue":"26","key":"5797_CR46","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1038\/onc.2013.310","volume":"33","author":"X Qian","year":"2014","unstructured":"Qian X, Anzovino A, Kim S, Suyama K, Yao J, Hulit J, Agiostratidou G, Chandiramani N, McDaid HM, Nagi C, Cohen HW, Phillips GR, Norton L, Hazan RB (2014) N-cadherin\/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem\/progenitor cell-like properties. Oncogene 33(26):3411\u20133421. https:\/\/doi.org\/10.1038\/onc.2013.310","journal-title":"Oncogene"},{"issue":"13","key":"5797_CR47","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.febslet.2010.12.001","volume":"585","author":"MR Estecio","year":"2011","unstructured":"Estecio MR, Issa JP (2011) Dissecting DNA hypermethylation in cancer. FEBS Lett 585(13):2078\u20132086. https:\/\/doi.org\/10.1016\/j.febslet.2010.12.001","journal-title":"FEBS Lett"},{"issue":"35","key":"5797_CR48","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400\u20135413. https:\/\/doi.org\/10.1038\/sj.onc.1205651","journal-title":"Oncogene"},{"issue":"2","key":"5797_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ng1719","volume":"38","author":"I Keshet","year":"2006","unstructured":"Keshet I, Schlesinger Y, Farkash S, Rand E, Hecht M, Segal E, Pikarski E, Young RA, Niveleau A, Cedar H, Simon I (2006) Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 38(2):149\u2013153. https:\/\/doi.org\/10.1038\/ng1719","journal-title":"Nat Genet"},{"issue":"11","key":"5797_CR50","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1073\/pnas.1013224108","volume":"108","author":"D Sproul","year":"2011","unstructured":"Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, Harrison DJ, Meehan RR, Sims AH, Ramsahoye BH (2011) Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci U S A 108(11):4364\u20134369. https:\/\/doi.org\/10.1073\/pnas.1013224108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5797_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/bfgp\/els063","volume":"12","author":"D Sproul","year":"2013","unstructured":"Sproul D, Meehan RR (2013) Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics 12(3):174\u2013190. https:\/\/doi.org\/10.1093\/bfgp\/els063","journal-title":"Brief Funct Genomics"},{"key":"5797_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaj2239","author":"Y Yin","year":"2017","unstructured":"Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S, Das PK, Kivioja T, Dave K, Zhong F, Nitta KR, Taipale M, Popov A, Ginno PA, Domcke S, Yan J, Schubeler D, Vinson C, Taipale J (2017) Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. https:\/\/doi.org\/10.1126\/science.aaj2239","journal-title":"Science"},{"issue":"1","key":"5797_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0012-1606(02)00119-7","volume":"256","author":"J Zhang","year":"2003","unstructured":"Zhang J, Brewer S, Huang J, Williams T (2003) Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis. Dev Biol 256(1):127\u2013145","journal-title":"Dev Biol"},{"key":"5797_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1471-2407-9-279","volume":"9","author":"H Ailan","year":"2009","unstructured":"Ailan H, Xiangwen X, Daolong R, Lu G, Xiaofeng D, Xi Q, Xingwang H, Rushi L, Jian Z, Shuanglin X (2009) Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells. BMC Cancer 9:279. https:\/\/doi.org\/10.1186\/1471-2407-9-279","journal-title":"BMC Cancer"},{"issue":"1","key":"5797_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12885-018-4845-0","volume":"18","author":"KM Mrozik","year":"2018","unstructured":"Mrozik KM, Blaschuk OW, Cheong CM, Zannettino ACW, Vandyke K (2018) N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer 18(1):939. https:\/\/doi.org\/10.1186\/s12885-018-4845-0","journal-title":"BMC Cancer"},{"issue":"1661","key":"5797_CR56","doi-asserted-by":"publisher","first-page":"20140039","DOI":"10.1098\/rstb.2014.0039","volume":"370","author":"OW Blaschuk","year":"2015","unstructured":"Blaschuk OW (2015) N-cadherin antagonists as oncology therapeutics. Philos Trans R Soc Lond B Biol Sci 370(1661):20140039. https:\/\/doi.org\/10.1098\/rstb.2014.0039","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"5797_CR57","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0378-CP","author":"MM Bui","year":"2019","unstructured":"Bui MM, Riben MW, Allison KH, Chlipala E, Colasacco C, Kahn AG, Lacchetti C, Madabhushi A, Pantanowitz L, Salama ME, Stewart RL, Thomas NE, Tomaszewski JE, Hammond ME (2019) Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists. Arch Pathol Lab Med. https:\/\/doi.org\/10.5858\/arpa.2018-0378-CP","journal-title":"Arch Pathol Lab Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05797-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05797-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05797-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T23:26:26Z","timestamp":1626564386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05797-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5797"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05797-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,18]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. An approval from the University of Pennsylvania Institutional Review Board committee with a waiver of written informed consent was used for analysis of patients\u2019 tissue and records.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}